[HTML][HTML] Comprehensive treatment outcomes of giant cell tumor of the spine: A retrospective study
K Hashimoto, S Nishimura, H Miyamoto, K Toriumi… - Medicine, 2022 - journals.lww.com
There is no consensus on a treatment strategy for spinal giant cell tumor of bone (GCTB)
because of the difficulty in their treatment. Treatment options often include the use of the …
because of the difficulty in their treatment. Treatment options often include the use of the …
Imaging features of aggressive giant cell tumors of the mobile spine: retrospective analysis of 101 patients from single center
B Yuan, L Zhang, S Yang, H Ouyang… - Global Spine …, 2022 - journals.sagepub.com
Study Design: Retrospective study. Objectives: Giant cell tumors (GCTs) of the mobile spine
can be locally aggressive. This study described and classified the typical and atypical …
can be locally aggressive. This study described and classified the typical and atypical …
[PDF][PDF] Postoperative Fracture Risk in Giant Cell Tumor: A Case Report and Review of Literature
Giant cell tumor (GCT) of the proximal femur poses various challenges in its management
and recurrence. We present a rare case of GCT of proximal femur in which recurrence and …
and recurrence. We present a rare case of GCT of proximal femur in which recurrence and …
Multimodal Management of Combined Posterior and Anterior Surgical Approach and Postoperative Pharmacological Therapy for Giant Cell Tumor of the Cervical …
Y Tsuji, Y Fukuo, T Kanemitsu, Y Katayama… - Neurologia medico …, 2022 - jstage.jst.go.jp
Giant cell tumor (GCT) of bone is essentially benign but locally aggressive, and the rate of
local recurrence is high when the resection is not enough. En bloc resection is …
local recurrence is high when the resection is not enough. En bloc resection is …
Giant cell tumor of the cervical spine treated by carbon ion radiotherapy: A case report
T Sakuda, T Furuta, T Okimoto, N Adachi - Medicine, 2021 - journals.lww.com
Interventions: The patient was started on denosumab at 15 years of age and received
carbon ion beam therapy with 70.4 Gy administered in 32 sessions over 7 weeks. Outcomes …
carbon ion beam therapy with 70.4 Gy administered in 32 sessions over 7 weeks. Outcomes …
Use of Denosumab and Serial Arterial Embolization Combination Therapy as an Alternative to Surgical Resection in a Case of Large Sacro-Pelvic Giant Cell Tumor
K Gupta, AP Jain, K Ahuja, S Mittal, P Kandwal - Neurology India, 2023 - journals.lww.com
Sir, Giant cell tumor (GCT) of the bone is considered a locally aggressive, intermediate‑
grade bone tumor that comprises 5% of primary bone tumors, with sacral tumors accounting …
grade bone tumor that comprises 5% of primary bone tumors, with sacral tumors accounting …
分子靶向治疗前的骨巨细胞瘤药物治疗
李远， 徐启明， 徐海荣， 牛晓辉 - 肿瘤综合治疗电子杂志, 2021 - jmcm2018.com
骨巨细胞瘤是一种具有多样生物学特性的原发交界性骨肿瘤, 好发于长骨的干骺端,
部分具有较强的侵袭性和较高的复发率. 骨巨细胞瘤的确切发病机制并不清楚 …
部分具有较强的侵袭性和较高的复发率. 骨巨细胞瘤的确切发病机制并不清楚 …